Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 137309-88-7
2. 2-(2-methoxyphenoxy)ethyl-4-methylbenzensulfonate
3. 2-(2-methoxyphenoxy)ethyl 4-methylbenzenesulfonate
4. Guaiacol Ethyltosylate Ether
5. 1631416b52
6. Ethanol, 2-(2-methoxyphenoxy)-, 1-(4-methylbenzenesulfonate)
7. Schembl9369968
8. Dtxsid101184959
9. Unii-1631416b52
10. Zinc26893932
11. Db-042388
12. Ft-0643265
13. 1-tosyloxy-2-(2-methoxyphenoxy)ethane
14. 309m887
15. Q27251766
| Molecular Weight | 322.4 g/mol |
|---|---|
| Molecular Formula | C16H18O5S |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 322.08749484 g/mol |
| Monoisotopic Mass | 322.08749484 g/mol |
| Topological Polar Surface Area | 70.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 409 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Guaiacol O-ethyltosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Guaiacol O-ethyltosylate, including repackagers and relabelers. The FDA regulates Guaiacol O-ethyltosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Guaiacol O-ethyltosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Guaiacol O-ethyltosylate supplier is an individual or a company that provides Guaiacol O-ethyltosylate active pharmaceutical ingredient (API) or Guaiacol O-ethyltosylate finished formulations upon request. The Guaiacol O-ethyltosylate suppliers may include Guaiacol O-ethyltosylate API manufacturers, exporters, distributors and traders.
click here to find a list of Guaiacol O-ethyltosylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Guaiacol O-ethyltosylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Guaiacol O-ethyltosylate active pharmaceutical ingredient (API) in detail. Different forms of Guaiacol O-ethyltosylate DMFs exist exist since differing nations have different regulations, such as Guaiacol O-ethyltosylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Guaiacol O-ethyltosylate DMF submitted to regulatory agencies in the US is known as a USDMF. Guaiacol O-ethyltosylate USDMF includes data on Guaiacol O-ethyltosylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Guaiacol O-ethyltosylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Guaiacol O-ethyltosylate suppliers with USDMF on PharmaCompass.
Guaiacol O-ethyltosylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Guaiacol O-ethyltosylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Guaiacol O-ethyltosylate GMP manufacturer or Guaiacol O-ethyltosylate GMP API supplier for your needs.
A Guaiacol O-ethyltosylate CoA (Certificate of Analysis) is a formal document that attests to Guaiacol O-ethyltosylate's compliance with Guaiacol O-ethyltosylate specifications and serves as a tool for batch-level quality control.
Guaiacol O-ethyltosylate CoA mostly includes findings from lab analyses of a specific batch. For each Guaiacol O-ethyltosylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Guaiacol O-ethyltosylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Guaiacol O-ethyltosylate EP), Guaiacol O-ethyltosylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Guaiacol O-ethyltosylate USP).
LOOKING FOR A SUPPLIER?
